Drugs / CJC 1295
last change Sep 2006 re-read 3 minutes ago

CJC 1295

Developed for
obesity disorder
Investigated by
ConjuChem

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00267527 Dec 2005 → Sep 2006 HIV infectious disease, obesity disorder ConjuChem Terminated No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CJC 1295 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00267527 ↗